Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
3,182,163
-
Total 13F shares
-
26,830,579
-
Share change
-
+812,745
-
Total reported value
-
$732,341,732
-
Price per share
-
$27.33
-
Number of holders
-
65
-
Value change
-
+$35,922,794
-
Number of buys
-
41
-
Number of sells
-
24
Institutional Holders of Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) as of Q2 2020
As of 30 Jun 2020,
Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,830,579 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, FRAZIER MANAGEMENT LLC, New Leaf Venture Partners, L.L.C., Vivo Capital, LLC, BOXER CAPITAL, LLC, BlackRock Inc., HIGHLINE CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, ALKEON CAPITAL MANAGEMENT LLC, and MORGAN STANLEY.
This page lists
65
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.